Ambu A/S (OTCMKTS:AMBBY) Shares Gap Down – Should You Sell?

Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) gapped down prior to trading on Friday . The stock had previously closed at $12.54, but opened at $11.7350. Ambu A/S shares last traded at $11.7350, with a volume of 500 shares trading hands.

Ambu A/S Stock Performance

The company has a market capitalization of $2.76 billion, a P/E ratio of 37.85 and a beta of 0.98. The stock’s fifty day moving average price is $13.28 and its 200-day moving average price is $14.25. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.67 and a current ratio of 2.86.

Ambu A/S (OTCMKTS:AMBBY) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $242.85 million for the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.